Smokers are less likely than non-smokers to have lung cancers caused by targetable genetic changes. But a study published in the journal iClinical Cancer Research/i shows that when they do, smokers benefit just as much as non-smokers from targeted treatments.
"A smoker or former smoker with a targetable alteration has the same probability of benefitting from targeted therapy as a never-smoker with a targetable alteration," says Dara Aisner, PhD, investigator at the University of Colorado Cancer ...
↧